scholarly journals Structural Basis of Multidrug Recognition by BmrR, a Transcription Activator of a Multidrug Transporter

Cell ◽  
1999 ◽  
Vol 96 (3) ◽  
pp. 353-362 ◽  
Author(s):  
Ekaterina E. Zheleznova ◽  
Penelope N. Markham ◽  
Alexander A. Neyfakh ◽  
Richard G. Brennan
2019 ◽  
Author(s):  
Ming Lei ◽  
Wolfram Tempel ◽  
Ke Liu ◽  
Jinrong Min

AbstractMeCP2 is an abundant protein, involved in transcriptional repression by binding to CG and non-CG methylated DNA. However, MeCP2 might also function as a transcription activator as MeCP2 is found bound to sparsely methylated promoters of actively expressed genes. Furthermore, Attachment Region Binding Protein (ARBP), the chicken ortholog of MeCP2, has been reported to bind to Matrix/scaffold attachment regions (MARs/SARs) DNA with an unmethylated 5’-CAC/GTG-3’ consensus sequence. In this study, we investigated how MeCP2 recognizes unmethylated 5’-CAC/GTG-3’ motif containing DNA by binding and structural studies. We found that MeCP2-MBD binds to MARs DNA with a comparable binding affinity to mCG DNA, and the MeCP2-CAC/GTG complex structure revealed that MeCP2 residues R111 and R133 form base-specific interactions with the GTG motif. For comparison, we also determined crystal structures of the MeCP2-MBD bound to mCG and mCAC/GTG DNA, respectively. Together, these crystal structures illustrate the adaptability of the MeCP2-MBD toward the GTG motif as well as the mCG DNA, and also provide structural basis of a biological role of MeCP2 as a transcription activator and its disease implications in Rett syndrome.


Nature ◽  
2013 ◽  
Vol 496 (7444) ◽  
pp. 247-251 ◽  
Author(s):  
Yoshiki Tanaka ◽  
Christopher J. Hipolito ◽  
Andrés D. Maturana ◽  
Koichi Ito ◽  
Teruo Kuroda ◽  
...  

2012 ◽  
Vol 393 (10) ◽  
pp. 1055-1066 ◽  
Author(s):  
Matthias Bochtler

Abstract Phytopathogen transcription activator-like effectors (TALEs) bind DNA in a sequence specific manner in order to manipulate host transcription. TALE specificity correlates with repeat variable diresidues in otherwise highly stereotypical 34–35mer repeats. Recently, the crystal structures of two TALE DNA-binding domains have illustrated the molecular basis of the TALE cipher. The structures show that the TALE repeats form a right-handed superhelix that is wound around largely undistorted B-DNA to match its helical parameters. Surprisingly, repeat variable residue 1 is not in contact with the bases. Instead, it is involved in hydrogen bonding interactions that stabilize the overall structure of the protein. Repeat variable residue 2 contacts the top strand base and forms sequence-specific hydrogen bonds and/or van der Waals contacts. Very unexpectedly, bottom strand bases are exposed to solvent and do not make any direct contacts with the protein. This review contains a summary of TALE biology and applications and a detailed description of the recent breakthroughs that have provided insights into the molecular basis of the TALE code.


2021 ◽  
pp. 166980
Author(s):  
Julia Kowal ◽  
Dongchun Ni ◽  
Scott M. Jackson ◽  
Ioannis Manolaridis ◽  
Henning Stahlberg ◽  
...  

2006 ◽  
Vol 357 (2) ◽  
pp. 481-492 ◽  
Author(s):  
Mathieu Rappas ◽  
Jörg Schumacher ◽  
Hajime Niwa ◽  
Martin Buck ◽  
Xiaodong Zhang

2020 ◽  
Vol 117 (42) ◽  
pp. 26245-26253 ◽  
Author(s):  
Kamil Nosol ◽  
Ksenija Romane ◽  
Rossitza N. Irobalieva ◽  
Amer Alam ◽  
Julia Kowal ◽  
...  

ABCB1 detoxifies cells by exporting diverse xenobiotic compounds, thereby limiting drug disposition and contributing to multidrug resistance in cancer cells. Multiple small-molecule inhibitors and inhibitory antibodies have been developed for therapeutic applications, but the structural basis of their activity is insufficiently understood. We determined cryo-EM structures of nanodisc-reconstituted, human ABCB1 in complex with the Fab fragment of the inhibitory, monoclonal antibody MRK16 and bound to a substrate (the antitumor drug vincristine) or to the potent inhibitors elacridar, tariquidar, or zosuquidar. We found that inhibitors bound in pairs, with one molecule lodged in the central drug-binding pocket and a second extending into a phenylalanine-rich cavity that we termed the “access tunnel.” This finding explains how inhibitors can act as substrates at low concentration, but interfere with the early steps of the peristaltic extrusion mechanism at higher concentration. Our structural data will also help the development of more potent and selective ABCB1 inhibitors.


Sign in / Sign up

Export Citation Format

Share Document